𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The quality of swallowing for patients with operable esophageal carcinoma : A randomized trial comparing surgery with radiotherapy

✍ Scribed by Rajendra A. Badwe; Vinay Sharma; Mehul S. Bhansali; Ketayun A. Dinshaw; Prakash K. Patil; Neelima Dalvi; Srinivas G. Rayabhattanavar; Prafulla B. Desai


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
84 KB
Volume
85
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Background:

Surgery is considered the standard treatment for operable esophageal carcinoma, although there is no compelling evidence that surgery can achieve better results than radiotherapy. there has previously been no direct randomized comparison of these two modalities with survival or disease specific outcome end points.

Methods:

Ninety-nine patients with operable squamous cell carcinoma of the esophagus were randomly allocated to surgery or radiotherapy after stratification for tumor length (< or = or >5 cm). those randomized to surgery underwent transthoracic esophagectomy with limited lymphadenectomy, whereas those in the radiotherapy arm received 50 gray in 28 fractions followed by a 15-gray boost to the primary tumor. disease specific outcome was assessed for 4 subgroups: 1) disease specific symptoms, 2) physical symptoms, 3) ability to work, and 4) social/family interaction and global perception of disease specific outcome. the questionnaire was given prior to treatment and posttreatment at 3-month intervals for 1 year. death was a secondary end point.

Results:

There was an overall improvement in the quality of swallowing in both treatment arms after treatment and with the passage of time. the swallowing status was better in the surgery arm than in the radiotherapy arm at 6 months after treatment (p = 0.03, fisher's exact test). logistic regression analysis showed randomization arm (p = 0.035), time since treatment (p = 0.003), and pretreatment swallowing status to be significant determinants of posttreatment swallowing status. surgery was twice as likely to result in improvement in swallowing than radiotherapy after correction for time and pretreatment swallowing status. overall survival was better in the surgery arm than in the radiotherapy arm (p = 0.002, log rank test) (or = 2.74 with 95% confidence intervals 1.51-4.98; p < 0.009, cox proportional hazards model).

Conclusions:

Both surgery and radiotherapy can improve the quality of swallowing significantly for patients with operable esophageal carcinoma. surgery is marginally superior to radiotherapy in improving the quality of swallowing. in this trial, survival in the surgery arm was significantly better than in the radiotherapy arm, although the small number of patients is a limitation.


πŸ“œ SIMILAR VOLUMES


A randomized clinical trial comparing co
✍ Bernard Lebeau; Thierry Urban; Jeanne-Marie BrΓ©chot; Dominique Paillotin; Jean V πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 116 KB πŸ‘ 1 views

## BACKGROUND. Although thoracic radiotherapy is considered to be useful for the treatment of patients with small cell lung carcinoma (SCLC), its optimal administration schedule is still controversial. ## METHODS. In a multicenter clinical trial, 164 patients with limited SCLC (of whom 156 were e

Preliminary report of the asian-oceanian
✍ Daniel T. T. Chua; Jonathan S. T. Sham; Damon Choy; Virchan Lorvidhaya; Yupa Sum πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 166 KB πŸ‘ 1 views

## BACKGROUND. The aim of this trial was to compare the outcome achieved with neoadjuvant chemotherapy followed by radiotherapy to that achieved with radiotherapy alone for patients with locoregionally advanced undifferentiated or poorly differentiated nasopharyngeal carcinoma (NPC) meeting one of

A randomized trial of long term adjuvant
✍ Kristina Dalberg; Hemming Johansson; Ulla Johansson; Lars E. Rutqvist πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 101 KB πŸ‘ 2 views

## BACKGROUND. The use of adjuvant tamoxifen to treat postmenopausal breast carcinoma patients as an adjunct to primary surgery is well established. The current study reports the long term results for a low risk stratum in a randomized trial of adjuvant tamoxifen. The main focus of this analysis w

Mature results of a Phase III randomized
✍ David J. Adelstein; Pierre Lavertu; Jerrold P. Saxton; Michelle Secic; Benjamin πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 102 KB πŸ‘ 2 views

The current study presents mature results from a Phase III randomized trial comparing radiation therapy and concurrent chemoradiotherapy in patients with resectable American Joint Committee on Cancer Stage III and IV disease.

Only pathologic complete response to neo
✍ Ermanno Ancona; Alberto Ruol; Stefano Santi; Stefano Merigliano; Vanna Chiarion πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 151 KB πŸ‘ 1 views